Today, the Select Committee on China released a new investigation uncovering how China buys oil from Iran, Russia, and Venezuela – three countries that are sanctioned by the United States. The investigation, Crude Intentions: How China Became the Cle

Today, the House Foreign Affairs Committee passed bipartisan legislation to curb the smuggling of American semiconductors to foreign adversaries. The Chip Security Act was introduced last year as a direct response to bipartisan concerns raised by the Select Committee on China in its report on Deepseek, which concluded the company used advanced chips produced by American semiconductor giant Nvidia that are restricted from export to the PRC to develop its AI model. 

Today, Chairman John Moolenaar (R-MI) and Ranking Member Ro Khanna (D-CA) of the House Select Committee on China, issued the following statement following reports that Taiwan was blocked from attending the 14th World Trade Organization (WTO) Ministerial Conference in Yaoundé, Cameroon:

“Cameroon’s decision to effectively exclude Taiwan from the 14th WTO Ministerial Conference in Yaoundé is another troubling example of China’s continued efforts to manipulate multilateral institutions.

Today, John Moolenaar, Chairman of the Select Committee on the China participated in a panel discussion at The Hill & Valley Forum on America’s strategy to win the competition in the artificial intelligence race against China. 

Joining leaders from Congress and industry, Moolenaar emphasized the urgent need for strong export controls, coordination with allies, and continued investment in American innovation to ensure the United States maintains its technological advantage.

During the conversation, Moolenaar underscored the stakes of the competition:

Select Committee on China Chairman John Moolenaar has sent letters to President Donald Trump and Secretary of State Marco Rubio urging them to advocate for the release of Chinese dissidents and sanction key Hong Kong officials.

In the letter to Trump, Moolenaar advocated for the release of China's prisoners of conscience—those jailed for their defense of human rights and religious freedom.

Today, the Federal Communications Commission prohibited foreign-adversary controlled networking equipment from being used in U.S. IT infrastructure. 

“Today’s tremendous decision by the FCC and the Trump Administration protects our country against China’s relentless cyberattacks and makes it clear that these devices should be excluded from our critical infrastructure. Routers are key to keeping us all connected and we cannot allow Chinese technology to be at the center of that. Additionally, I urge our national security agencies to keep shutting down the glaring vulnerabilities throughout the American IT supply chain, including Chinese-made cellular modules, networked sensors, industrial robots, and energy grid equipment,” said Chairman John Moolenaar of the Select Committee on China.

Chairman John Moolenaar of the Select Committee on China made the following statement on the Justice Department’s filing of charges

Today, Select Committee on China Chairman John Moolenaar discussed China’s malign influence at the United Nations with Michael Waltz, America's Ambassador to the UN. At a House Appropriations Committee field hearing at the U.S.

Select Committee on China Chairman John Moolenaar has sent a letter to Secretary of War Pete Hegseth concerning the operations of French aerospace company Safran in China and the French government's role in impeding the Select Committee’s investigation into aerospace industry activities in China.

Today, the Select Committee on China released a new investigation uncovering how China is manipulating its position at the United Nations to undermine America's interests and advance its international ambitions.

Today, Select Committee on China Chairman John Moolenaar delivered this opening statement at the Select Committee’s hearing on the generic drug supply chain – roughly 90% of drugs Americans take every day run through Chinese-controlled inputs – and the drug development pipeline, where China is close to outpacing the U.S. in clinical trials.

As prepared for delivery.

"China is cornering the market on our medicines — from the supply of generic drugs that Americans depend on every day, to the cutting-edge biotech pipeline that will determine who leads medicine in the years and decades ahead.

"For most of American history, when a doctor prescribed a medication, it was made in our country, or somewhere we trusted. That is no longer true — and it’s a problem many Americans are unaware of.

Today, Select Committee on China Chairman John Moolenaar sent a letter to the National Science Foundation (NSF) demanding it pause funding and conduct an investigation into the research security practices of the University of Washingt